Product Program year 2022 Source: CMS Open Payments

Alkindi

Drug Replacement therapy for pediatric patients with AI (ALKINDI PI)

NDC 71863-109-50

Open in the dashboard

General payments

$908

88 payments

Research payments

$0

0 payments

Through program year 2022, $908 in general payments and $0 in research payments were reported against Alkindi (Replacement therapy for pediatric patients with AI (ALKINDI PI)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $908 88

Breakdown

Who paid General payments · program year 2022
  1. TOLMAR Pharmaceuticals, Inc. $908 88 payments
Top recipients General payments · program year 2022
  1. Michael Wood Pediatric Endocrinology · Ypsilanti, MI $61 7% · 30 payments
  2. Soumya Nagaraja Pediatric Endocrinology · Mesa, AZ $43 5% · 2 payments
  3. Jennifer Kyllo Pediatric Endocrinology · St Paul, MN $40 4% · 2 payments
  4. Kevin Sheridan Endocrinology, Diabetes & Metabolism · Saint Paul, MN $40 4% · 1 payment
  5. Kyriakie Sarafoglou Pediatrics · Minneapolis, MN $40 4% · 1 payment

The top 5 of 45 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Pediatric Endocrinology Pediatrics $612 67% · 30 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $87 10% · 3 practitioners
  3. Pediatrics $84 9% · 3 practitioners
  4. Nurse Practitioner, Pediatrics Nurse Practitioner $64 7% · 5 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $44 5% · 3 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Minnesota $197 22% · 7 recipients
  2. Michigan $118 13% · 3 recipients
  3. Florida $66 7% · 4 recipients
  4. New York $64 7% · 3 recipients
  5. Arizona $55 6% · 2 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

88 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record